REG - Angola(Republic of) - Publication of Pricing Supplement
12/04/2022 16:00
For best results when printing this announcement, please click on link below: http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220412:nRSL1612Ia&default-theme=true RNS Number : 1612I Angola (The Republic of) 12 April 2022 Publication of Pricing Supplement. The pricing supplement in relation to the issue of U.S.$1,750,000,000 8.75% per cent. Notes due 2032 by the Republic of Angola (the "Issuer") under the Issuer's Global Medium Term Note Programme (the "Pricing Supplement") is available for viewing. To view the full document, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/1612I_1-2022-4-12.pdf (http://www.rns-pdf.londonstockexchange.com/rns/1612I_1-2022-4-12.pdf) For further information, please contact: Dorivaldo F. S. Teixeira Director - Public Debt Management Unit -Ministry of Finance Republic of Angola Ministry of Finance Building Largo da Matumba Luanda Republic of Angola Tel: +244 222 70 60 77 E-Mail: dorivaldo.teixeira@minfin.gov.ao (mailto:dorivaldo.teixeira@minfin.gov.ao) Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below. DISCLAIMER - INTENDED ADDRESSEES Please note that the information contained in this announcement and the Pricing Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Pricing Supplement) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Pricing Supplement is not addressed. Prior to relying on the information contained in the Pricing Supplement, you must ascertain from the Pricing Supplement whether or not you are part of the intended addressees of the information contained therein. In particular, this announcement and the Pricing Supplement do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction. The securities referred to in the announcement and the Pricing Supplement have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act, and the rules and regulations thereunder. The Issuer does not intend to register any of the securities referred to in the announcement and the Pricing Supplement in the United States or to conduct a public offering of the securities referred to in the announcement and the Pricing Supplement in the United States or elsewhere. The Pricing Supplement has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Issuer or its advisers accepts any liability or responsibility whatsoever in respect of any difference between the Pricing Supplement made available to you in electronic format and the hard copy version available to you on request from the Issuer. Your right to access this service is conditional upon complying with the above requirement. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit www.rns.com (http://www.rns.com/) . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) . END PFTSFSFDEEESEIL